8月12日工银医疗保健股票净值下跌0.62%，近1个月累计上涨6.78%

Group 1 - The core viewpoint of the news is the performance and holdings of the Industrial and Commercial Bank of China Medical Healthcare Stock Fund, which has shown significant returns over various time frames [1] - The fund's latest net value is 2.8960 yuan, with a recent decline of 0.62%. Over the past month, the fund has achieved a return of 6.78%, ranking 325 out of 656 in its category. In the last six months, the return was 25.80%, ranking 82 out of 637, and since the beginning of the year, it has returned 27.07%, ranking 113 out of 635 [1] - The top ten holdings of the fund account for a total of 44.59%, with significant positions in companies such as Heng Rui Pharmaceutical (7.52%), Kelun Pharmaceutical (6.50%), and BeiGene (5.08%) [1] Group 2 - The fund was established on November 18, 2014, and as of June 30, 2025, it has a total scale of 2.797 billion yuan. The fund managers are Zhao Bei and Ding Yang [1] - Zhao Bei holds a master's degree and has extensive experience in the healthcare sector, having been the fund manager since the fund's inception. Ding Yang, a PhD holder, joined the company in December 2017 and has been involved in various fund management roles [2]